Publications by authors named "Jacquelyn Haskell"

Claim this Profile
T
Topical resiquimod protects against visceral infection with Leishmania infantum chagasi in mice.
Noah Craft, Ron Birnbaum, Natalie Quanquin, Marie Crisel B Erfe, Cara Quant, Jacquelyn Haskell

Clin Vaccine Immunol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Killed but metabolically active Leishmania infantum as a novel whole-cell vaccine for visceral leishmaniasis.
Kevin W Bruhn, Ron Birnbaum, Jacquelyn Haskell, Veena Vanchinathan, Stephanie Greger

Clin Vaccine Immunol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of synthetic peptides RP-1 and AA-RP-1 against Leishmania species in vitro and in vivo.
Marie Crisel B Erfe, Consuelo V David, Cher Huang, Victoria Lu, Ana Claudia Maretti-Mira, Jacquelyn Haskell

Antimicrob Agents Chemother· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulation by imiquimod in patients with high-risk primary melanoma.
Rupa Narayan, Hong Nguyen, Jason J Bentow, Lauren Moy, Diana K Lee, Jacquelyn Haskell

J Invest Dermatol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LXR deficiency confers increased protection against visceral Leishmania infection in mice.
Kevin W Bruhn, Chaitra Marathe, Ana Cláudia Maretti-Mira, Hong Nguyen, Jacquelyn Haskell

PLoS Negl Trop Dis· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis